NEI VFQ-25 subscale scores and OCS compared with literature.

<p>NEI VFQ-25 subscale scores and OCS compared with literature.</p

NEI VFQ-25 subscale scores and overall composite score (OCS), Mean ± SD.

<p>NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, HSV: Herpes Simplex Virus, VZV: Varicella Zoster Virus. Mean scores ± one standard deviation are given.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b Bonferroni correction, significance level p<0.017. ^c Missing data in three patients.</p

NEI VFQ-25 subscale scores and overall composite score (OCS), Mean ± SD.

<p>NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, IOP: Intraocular Pressure. Mean scores ± one standard deviation are given.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b No keratitis in history or keratitis in history without residuals. ^c Keratitis with residuals. ^d Medical chronic condition or medical condition with large impact, recent or in the past, except for uveitis. ^e At least one eye with Snellen visual acuity <0.5. Measured with Snellen chart within six months before or after completing the NEI VFQ-25. ^f Missing data in four patients. ^g Treatment of the uveitis and/or complications at the moment of completing the NEI VFQ-25.</p

NEI VFQ-25 subscale scores and OCS compared with literature.

<p>NEI VFQ-25: National Eye Institute Visual Function Questionnaire-25. GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b 12 months after receiving infliximab. ^c Six week follow-up visit.</p

Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.

<p>NEI VFQ-25: National Eye Institute Visual Function Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, VA: Visual Acuity, BDI: Beck Depression Inventory, SSL-I: Social Support List - Interactions, SSL-D: Social Support List – Discrepancies.</p><p>^a Average of vision-targeted subscale scores, without GH.</p

clinical characteristics of HLA-B27 associated AU patients and overall scores on questionnaires (N and (%) or Mean ± SD (range)).

<p>clinical characteristics of HLA-B27 associated AU patients and overall scores on questionnaires (N and (%) or Mean ± SD (range)).</p

Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.

<p>Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.</p

NEI VFQ-25 subscale scores and ocular composite score (OCS), Mean ± S.

<p>NEI VFQ-25 subscale scores and ocular composite score (OCS), Mean ± S.</p

Data on patients, operated eyes and surgical procedure.

<p>SD: Standard deviation, TPPV: Trans pars plana vitrectomy. BCVA: Best corrected visual acuity. SAC: Sine Amsler chart.</p><p>Data on patients, operated eyes and surgical procedure.</p

Type VII collagen is visualized within corpora amylacea (T8100).

<p>Immuno-electron microscopic image of the inner plexiform layer of a human retina. Immunogold-labeled polyclonal antibody directed against type VII collagen labels two corpora amylacea diffusely. Within the corpora amylacea, there is no evidence of fibrillar collagen or banding. Some background labeling is present. Bar 10 μm.</p